Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 8/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 8/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | IL1B | P01584 | 4/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25506898 | 0.82 | CHRM4 (0.60) | CHRM2CHRM4CYP3A4CYP1A2CYP2B6 | |
| SCHEMBL25506606 | 0.82 | CHRM4 (0.60) | CHRM2CHRM4CYP3A4CYP1A2CYP2B6 | |
| SCHEMBL30382372 | 0.82 | CHRM4 (0.60) | CHRM2CHRM4CYP3A4CYP1A2CYP2B6 | |
| Hydrochloric Acid SCHEMBL25197633 | 0.81 | CHRM4 (0.59) | CHRM2CHRM4CYP3A4CYP1A2CYP2B6 | |
| Hydrochloric Acid SCHEMBL29919567 | 0.81 | CHRM4 (0.59) | CHRM2CHRM4CYP3A4CYP1A2CYP2B6 | |
| SCHEMBL25191747 | 0.79 | CHRM2 (0.46) | CHRM2CHRM4CYP3A4CYP1A2CYP2B6 | |
| SCHEMBL25191574 | 0.79 | CHRM2 (0.46) | CHRM2CHRM4CYP3A4CYP1A2CYP2B6 | |
| SCHEMBL23499308 | 0.74 | CHRM4 (0.75) | CHRM2CHRM4CYP3A4CYP1A2CYP2B6 | |
| SCHEMBL30383032 | 0.74 | CHRM4 (0.75) | CHRM2CHRM4CYP3A4CYP1A2CYP2B6 | |
| SCHEMBL23499276 | 0.74 | CHRM4 (0.75) | CHRM2CHRM4CYP3A4CYP1A2CYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230150986-A1 | ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | UNITED STATES GOVERNMENT | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150986-A1 | ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | CHRM3, CHRM2, CHRM4 | CHRM2 2/4885CHRM4 3/4885CYP3A4 1040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.